SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: wvalx who wrote (21518)4/29/1999 10:52:00 PM
From: wvalx  Respond to of 23519
 
<Annual Scientific Meeting
Sunday, May 2, 1999 1:00 P.M. - 6:00 P.M.
Stemmons Auditorium, Wyndham Anatole Hotel
Dallas, Texas

1:00 p.m. Sildenafil, One Year Later - Experience in Impotence Practice: Data on Prescriptions Written, New Implants Placed, Vacuum Erection Devices, Intracavernous Injections, Intraurethral Therapy
1:15 p.m. The Cardiologist's Perspective of Sildenafil: Precautions for the Use of Sildenafil in Cardiac Patients
1:45 p.m. The Ophthalmologist's Perspective of Sildenafil: Concerns Regarding the Use of Sildenafil
2:15 p.m. Evaluation of Erectile Dysfunction in the Era of Sildenafil: What to do When Sildenafil Fails
2:50 p.m. Break
3:05 p.m. Reimbursement for Diagnosis and Treatment of Erectile Dysfunction: How to Approach Third Party Payors
3:30 p.m. New Therapies for Erectile Dysfunction: What's on the Horizon?
4:15 p.m. Penile Straightening in Peyronie's Disease: Which Materials are Suitable for Replacement of the Tunica Albuginea?
5:00 p.m. Annual Business Meeting of the Society for the Study of Impotence
6:00 p.m. Adjourn

Hell, I thought "Tunica Albuginea" was his real name, from Turkey or somewhere like that. Hopefully the answer to 2:15pm will be MUSE or MUSE/Viagra combo.



To: wvalx who wrote (21518)4/30/1999 7:59:00 AM
From: Edderd  Read Replies (1) | Respond to of 23519
 
wvalx
Alza rep told me yesterday one of their people was leaving to join Vivus as a regional manager? or resource for urologists. Looks like Vivus is going small time for the moment on their own. Not sure I understand the strategy or maybe it is in the likelyhood that alibra is ready to hit the market. I don't have a laptop so I won't be posting from Dallas but I'll catch up when I get back on Tues. This is a working trip for me.
Ed